Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneously Integrated Brain Metastases Boost: A Planning Study

Alonso N. Gutiérrez, David C. Westerly, Wolfgang A. Tome, Hazim A. Jaradat, Thomas R. Mackie, Søren M. Bentzen, Deepak Khuntia, Minesh P. Mehta

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Purpose: To evaluate the feasibility of using tomotherapy to deliver whole brain radiotherapy with hippocampal avoidance, hypothesized to reduce the risk of memory function decline, and simultaneously integrated boost to brain metastases to improve intracranial tumor control. Methods and Materials: Ten patients treated with radiosurgery and whole brain radiotherapy underwent repeat planning using tomotherapy with the original computed tomography scans and magnetic resonance imaging-computed tomography fusion-defined target and normal structure contours. The individually contoured hippocampus was used as a dose-limiting structure (<6 Gy); the whole brain dose was prescribed at 32.25 Gy to 95% in 15 fractions, and the simultaneous boost doses to individual brain metastases were 63 Gy to lesions ≥2.0 cm in the maximal diameter and 70.8 Gy to lesions <2.0 cm. The plans were generated with a field width (FW) of 2.5 cm and, in 5 patients, with a FW of 1.0 cm. The plans were compared regarding conformation number, prescription isodose/target volume ratio, target coverage, homogeneity index, and mean normalized total dose. Results: A 1.0-cm FW compared with a 2.5-cm FW significantly improved the dose distribution. The mean conformation number improved from 0.55 ± 0.16 to 0.60 ± 0.13. Whole brain homogeneity improved by 32% (p <0.001). The mean normalized total dose to the hippocampus was 5.9 ± 1.3 Gy2 and 5.8 ± 1.9 Gy2 for 2.5- and 1.0-cm FW, respectively. The mean treatment delivery time for the 2.5- and 1.0-cm FW plans was 10.2 ± 1.0 and 21.8 ± 1.8 min, respectively. Conclusion: Composite tomotherapy plans achieved three objectives: homogeneous whole brain dose distribution equivalent to conventional whole brain radiotherapy; conformal hippocampal avoidance; and radiosurgically equivalent dose distributions to individual metastases.

Original languageEnglish (US)
Pages (from-to)589-597
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume69
Issue number2
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

avoidance
metastasis
acceleration (physics)
brain
planning
radiation therapy
Radiotherapy
Neoplasm Metastasis
dosage
Brain
hippocampus
lesions
homogeneity
Hippocampus
tomography
Tomography
Radiosurgery
Prescriptions
magnetic resonance
delivery

Keywords

  • Brain metastases
  • Conformal avoidance
  • Hippocampus
  • Tomotherapy
  • Whole brain

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneously Integrated Brain Metastases Boost : A Planning Study. / Gutiérrez, Alonso N.; Westerly, David C.; Tome, Wolfgang A.; Jaradat, Hazim A.; Mackie, Thomas R.; Bentzen, Søren M.; Khuntia, Deepak; Mehta, Minesh P.

In: International Journal of Radiation Oncology Biology Physics, Vol. 69, No. 2, 01.10.2007, p. 589-597.

Research output: Contribution to journalArticle

Gutiérrez, Alonso N. ; Westerly, David C. ; Tome, Wolfgang A. ; Jaradat, Hazim A. ; Mackie, Thomas R. ; Bentzen, Søren M. ; Khuntia, Deepak ; Mehta, Minesh P. / Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneously Integrated Brain Metastases Boost : A Planning Study. In: International Journal of Radiation Oncology Biology Physics. 2007 ; Vol. 69, No. 2. pp. 589-597.
@article{8964968eb02948208130a78237e11c73,
title = "Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneously Integrated Brain Metastases Boost: A Planning Study",
abstract = "Purpose: To evaluate the feasibility of using tomotherapy to deliver whole brain radiotherapy with hippocampal avoidance, hypothesized to reduce the risk of memory function decline, and simultaneously integrated boost to brain metastases to improve intracranial tumor control. Methods and Materials: Ten patients treated with radiosurgery and whole brain radiotherapy underwent repeat planning using tomotherapy with the original computed tomography scans and magnetic resonance imaging-computed tomography fusion-defined target and normal structure contours. The individually contoured hippocampus was used as a dose-limiting structure (<6 Gy); the whole brain dose was prescribed at 32.25 Gy to 95{\%} in 15 fractions, and the simultaneous boost doses to individual brain metastases were 63 Gy to lesions ≥2.0 cm in the maximal diameter and 70.8 Gy to lesions <2.0 cm. The plans were generated with a field width (FW) of 2.5 cm and, in 5 patients, with a FW of 1.0 cm. The plans were compared regarding conformation number, prescription isodose/target volume ratio, target coverage, homogeneity index, and mean normalized total dose. Results: A 1.0-cm FW compared with a 2.5-cm FW significantly improved the dose distribution. The mean conformation number improved from 0.55 ± 0.16 to 0.60 ± 0.13. Whole brain homogeneity improved by 32{\%} (p <0.001). The mean normalized total dose to the hippocampus was 5.9 ± 1.3 Gy2 and 5.8 ± 1.9 Gy2 for 2.5- and 1.0-cm FW, respectively. The mean treatment delivery time for the 2.5- and 1.0-cm FW plans was 10.2 ± 1.0 and 21.8 ± 1.8 min, respectively. Conclusion: Composite tomotherapy plans achieved three objectives: homogeneous whole brain dose distribution equivalent to conventional whole brain radiotherapy; conformal hippocampal avoidance; and radiosurgically equivalent dose distributions to individual metastases.",
keywords = "Brain metastases, Conformal avoidance, Hippocampus, Tomotherapy, Whole brain",
author = "Guti{\'e}rrez, {Alonso N.} and Westerly, {David C.} and Tome, {Wolfgang A.} and Jaradat, {Hazim A.} and Mackie, {Thomas R.} and Bentzen, {S{\o}ren M.} and Deepak Khuntia and Mehta, {Minesh P.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1016/j.ijrobp.2007.05.038",
language = "English (US)",
volume = "69",
pages = "589--597",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Whole Brain Radiotherapy With Hippocampal Avoidance and Simultaneously Integrated Brain Metastases Boost

T2 - A Planning Study

AU - Gutiérrez, Alonso N.

AU - Westerly, David C.

AU - Tome, Wolfgang A.

AU - Jaradat, Hazim A.

AU - Mackie, Thomas R.

AU - Bentzen, Søren M.

AU - Khuntia, Deepak

AU - Mehta, Minesh P.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Purpose: To evaluate the feasibility of using tomotherapy to deliver whole brain radiotherapy with hippocampal avoidance, hypothesized to reduce the risk of memory function decline, and simultaneously integrated boost to brain metastases to improve intracranial tumor control. Methods and Materials: Ten patients treated with radiosurgery and whole brain radiotherapy underwent repeat planning using tomotherapy with the original computed tomography scans and magnetic resonance imaging-computed tomography fusion-defined target and normal structure contours. The individually contoured hippocampus was used as a dose-limiting structure (<6 Gy); the whole brain dose was prescribed at 32.25 Gy to 95% in 15 fractions, and the simultaneous boost doses to individual brain metastases were 63 Gy to lesions ≥2.0 cm in the maximal diameter and 70.8 Gy to lesions <2.0 cm. The plans were generated with a field width (FW) of 2.5 cm and, in 5 patients, with a FW of 1.0 cm. The plans were compared regarding conformation number, prescription isodose/target volume ratio, target coverage, homogeneity index, and mean normalized total dose. Results: A 1.0-cm FW compared with a 2.5-cm FW significantly improved the dose distribution. The mean conformation number improved from 0.55 ± 0.16 to 0.60 ± 0.13. Whole brain homogeneity improved by 32% (p <0.001). The mean normalized total dose to the hippocampus was 5.9 ± 1.3 Gy2 and 5.8 ± 1.9 Gy2 for 2.5- and 1.0-cm FW, respectively. The mean treatment delivery time for the 2.5- and 1.0-cm FW plans was 10.2 ± 1.0 and 21.8 ± 1.8 min, respectively. Conclusion: Composite tomotherapy plans achieved three objectives: homogeneous whole brain dose distribution equivalent to conventional whole brain radiotherapy; conformal hippocampal avoidance; and radiosurgically equivalent dose distributions to individual metastases.

AB - Purpose: To evaluate the feasibility of using tomotherapy to deliver whole brain radiotherapy with hippocampal avoidance, hypothesized to reduce the risk of memory function decline, and simultaneously integrated boost to brain metastases to improve intracranial tumor control. Methods and Materials: Ten patients treated with radiosurgery and whole brain radiotherapy underwent repeat planning using tomotherapy with the original computed tomography scans and magnetic resonance imaging-computed tomography fusion-defined target and normal structure contours. The individually contoured hippocampus was used as a dose-limiting structure (<6 Gy); the whole brain dose was prescribed at 32.25 Gy to 95% in 15 fractions, and the simultaneous boost doses to individual brain metastases were 63 Gy to lesions ≥2.0 cm in the maximal diameter and 70.8 Gy to lesions <2.0 cm. The plans were generated with a field width (FW) of 2.5 cm and, in 5 patients, with a FW of 1.0 cm. The plans were compared regarding conformation number, prescription isodose/target volume ratio, target coverage, homogeneity index, and mean normalized total dose. Results: A 1.0-cm FW compared with a 2.5-cm FW significantly improved the dose distribution. The mean conformation number improved from 0.55 ± 0.16 to 0.60 ± 0.13. Whole brain homogeneity improved by 32% (p <0.001). The mean normalized total dose to the hippocampus was 5.9 ± 1.3 Gy2 and 5.8 ± 1.9 Gy2 for 2.5- and 1.0-cm FW, respectively. The mean treatment delivery time for the 2.5- and 1.0-cm FW plans was 10.2 ± 1.0 and 21.8 ± 1.8 min, respectively. Conclusion: Composite tomotherapy plans achieved three objectives: homogeneous whole brain dose distribution equivalent to conventional whole brain radiotherapy; conformal hippocampal avoidance; and radiosurgically equivalent dose distributions to individual metastases.

KW - Brain metastases

KW - Conformal avoidance

KW - Hippocampus

KW - Tomotherapy

KW - Whole brain

UR - http://www.scopus.com/inward/record.url?scp=34548507015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548507015&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2007.05.038

DO - 10.1016/j.ijrobp.2007.05.038

M3 - Article

C2 - 17869672

AN - SCOPUS:34548507015

VL - 69

SP - 589

EP - 597

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -